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Background: Generalized progressive retinal atrophy (PRA) is a group of inherited eye diseases characterised by
progressive retinal degeneration that ultimately leads to blindness in dogs. To date, more than 20 different
mutations causing canine-PRA have been described and several breeds including the Golden Retriever are affected
by more than one form of PRA. Genetically distinct forms of PRA may have different clinical characteristics such as
rate of progression and age of onset. However, in many instances the phenotype of different forms of PRA cannot
be distinguished at the basic clinical level achieved during routine ophthalmoscopic examination. Mutations in two
distinct genes have been reported to cause PRA in Golden Retrievers (prcd-PRA and GR_PRA1), but for
approximately 39% of cases in this breed the causal mutation remains unknown.
Results: A genome-wide association study of 10 PRA cases and 16 controls identified an association on chromosome
8 not previously associated with PRA (praw = 1.30×10
−6 and corrected with 100,000 permutations, pgenome = 0.148).
Using haplotype analysis we defined a 737 kb critical region containing 6 genes. Two of the genes (TTC8 and
SPATA7) have been associated with Retinitis Pigmentosa (RP) in humans. Using targeted next generation
sequencing a single nucleotide deletion was identified in exon 8 of the TTC8 gene of affected Golden Retrievers.
The frame shift mutation was predicted to cause a premature termination codon. In a larger cohort, this mutation,
TTC8c.669delA, segregates correctly in 22 out of 29 cases tested (75.9%). Of the PRA controls none are homozygous
for the mutation, only 3.5% carry the mutation and 96.5% are homozygous wildtype.
Conclusions: Our results show that PRA is genetically heterogeneous in one of the world’s numerically largest
breeds, the Golden Retriever, and is caused by multiple, distinct mutations. Here we discuss the mutation that
causes a form of PRA, that we have termed PRA2, that accounts for approximately 30% of PRA cases in the breed.
The genetic explanation for approximately 9% of cases remains to be identified. PRA2 is a naturally occurring
animal model for Retinitis Pigmentosa, and potentially Bardet-Biedl Syndrome.Lay summary
Progressive retinal atrophy (PRA) is a group of inherited
eye disorders that occur in many different dog breeds.
Each form of PRA shows a simple pattern of mendelian
inheritance, and is due to a mutation in one gene. How-
ever, over 20 different PRA-causing mutations have now
been identified in a number of different genes. Some
breeds, including Golden Retrievers (GR), may have more
than one genetic form of PRA.* Correspondence: cathryn.mellersh@aht.org.uk
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unless otherwise stated.Canine PRA is considered to be the equivalent of
Retinitis Pigmentosa (RP), which is a group of inherited
human eye diseases.
This paper has identified a gene called TTC8 that is
associated with PRA in GR. Interestingly the human
TTC8 gene has previously been associated with RP.
There is a one DNA base deletion in the gene which re-
sults in a shorter than normal protein to be made by the
faulty version of the gene.
All the cases in this study were genetically screened
for the other two known mutations for PRA in GR, and
none were homozygous (two copies) for either of those
mutations.
The gene was first identified by whole genome scanning
10 cases and 16 controls. A single mutation was identifiedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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screening a larger number of dogs.
Background
In animals inherited and progressive retinal diseases are
commonly referred to as progressive retinal atrophy
(PRA), which is characterised by a progressive bilateral
retinal degeneration resulting in loss of vision. In typical
PRA rod photoreceptor responses are lost first followed
by cone photoreceptor responses [1]. Fundus changes ob-
served in PRA are bilateral and symmetrical and include
tapetal hyper-reflectivity in the early stages followed by
vascular attenuation, pigmetary changes and atrophy of
the optic nerve head in the later stages of disease [2].
Numerous, genetically distinct, forms of PRA have been
documented in more than 100 dog breeds and while they
exhibit similar clinical signs, the aetiology, age of onset
and rate of progression may vary both between and within
breeds. While a particular mutation (and corresponding
form of PRA) may be shared by multiple breeds, due to
the population structure of the domestic dog most PRA-
affected dogs within a single breed are expected to share
the same mutation. At least 20 disease-causing mutations
have so far been associated with PRA. Most of them are
autosomal recessive diseases but there are examples of
X-linked as well as dominant PRA-disorders in dogs
(for review see [3]). However, the causative mutation for
many forms of PRA remains undefined. PRA is consid-
ered the veterinary equivalent of Retinitis Pigmentosa
(RP), which is the collective name for a group of inherited
human retinal disorders that leads to progressive loss of
vision in approximately 1 in 4000 people [4-6]. Rod photo-
receptor cells are predominantly affected and therefore
clinical symptoms typically include night blindness and
loss of peripheral vision. With disease progression the
cones also degenerate resulting in central vision loss and
eventually complete blindness is possible. To date, more
than 192 genes have been shown to cause a wide spectrum
of human retinal disease, including RP [7]. Mutations in
these genes currently only account for approximately 30%
of autosomal recessive RP cases [8]. RP is also a major
component of a number of systemic diseases including
Bardet-Biedl Syndrome (BBS).
Canine diseases have already proved valuable natural
models for the study of many varied human conditions
such as cardiac conotruncal malformations [9], myotub-
ular myopathy [10] and hereditary retinopathies such as
Leber congenital amaurosis (LCA) and achromatopsia
[11,12]. Further to this, canine models for human eye
diseases have proved invaluable in gene-therapy studies,
most notably the canine model of LCA associated with
RPE65 [13-17].
Most PRA cases in the Golden Retriever (GR) are
clinically indistinguishable from PRA cases of otherbreeds. The mode of inheritance appears from pedigree
information to be consistent with autosomal recessive
and the age of diagnosis is most commonly at approxi-
mately 5 years of age [18]. We previously identified a
form of PRA, GR_PRA1, caused by a mutation in the
SLC4A3 gene that accounts for the majority (61%) of
cases of PRA in the GR breed [18]. In the closely related
Labrador Retriever (LR) breed, a mutation in the PRCD
(progressive rod cone degeneration) gene can explain
the majority of PRA cases [19]. The PRCD-mutation
has also been associated with PRA in a small number of
PRA-affected GRs [18].
Here we report the identification of a single base dele-
tion in the TTC8 gene, which is one of seven genes en-
coding a protein complex (BBSome) that has been
proposed to promote ciliary membrane biogenesis and
to be an important factor in the development of Bardet-
Biedl Syndrome [20]. The deletion causes a shift in the
reading frame resulting in a subsequent premature ter-
mination codon. We present evidence that this putative
loss-of-function mutation represents a third susceptibility
locus for PRA, known hereafter as GR_PRA2, in Golden
Retrievers.
Results
PRCD and PRA1 screening
To exclude the possibility that the affected GRs were posi-
tive for the mutations already known to cause prcd-PRA
or GR_PRA1, all 29 GR cases in our study were screened
for the previously described, autosomal recessive PRCD
[19] and GR_PRA1 mutations [18]. None of the affected
GRs were homozygous for either of these mutations. A
single individual was heterozygous for the PRCD mutation
and five were heterozygous for the GR_PRA1 mutation,
while the remaining 23 were homozygous for the wildtype
(normal) alleles at both loci.
Genome-wide association mapping
Ten PRA-affected Golden Retrievers and 16 healthy con-
trols (all but two of which were over the age of seven years
when last examined) were genotyped with the 170 k Cani-
neHD BeadChips (Illumina). After filtering, 103,264 SNPs
were used in a Genome-wide association (GWA) analysis
and a genome-wide significant association was found on
chromosome 8 (CFA8; praw = 1.303×10
−6, pgenome = 0.036).
Identity-by-state (IBS) clustering using genome-wide SNP
marker data confirmed the presence of population stratifi-
cation with a genomic inflation factor > 1 (λ = 1.32). After
correction for stratification by analysing for association
with a CMH meta-analysis the signal on CFA8 remained
the strongest signal (praw = 8.99×10
−5) and the inflation
factor was reduced (λ = 0.86) (Figure 1). While the signal
dropped below the level of significance after correcting for
multiple testing (pgenome = 0.148; Figure 1), the reduction
Figure 1 Genome-wide association mapping of PRA in Golden Retrievers. -Log10 of p-values after correction for multiple testing and population
stratification with 100,000 permutations and IBS clustering, respectively. (A) -Log10 plot of genome-wide association results show a single, albeit
not statistically significant, signal on CFA8 (praw = 8.99 × 10
−5, pgenome = 0.148). The most significant of the raw and permuted values are
indicated. (B) The associated SNPs on CFA8 form two distinct signals with the most associated SNPs at 63.614 Mb and 71.732 Mb. Permuted
values at these loci are indicated.
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correction. The signal on CFA8, nevertheless remained
the only associated region observed anywhere on the
genome and extended from 63.600 to 71.732 Mb with
the most significantly associated SNP, BICF2G630416812
(pgenome = 0.148) at 71.732 Mb. Further investigation of
the signal on CFA8 revealed that it was formed by two
apparently independent and distinct signals with the
most highly associated SNPs at 63.614 Mb (BICF2P582923;
praw = 1.16×10
−4; pgenome = 0.197) and 71.732 Mb (BICF2
G630416812; praw = 8.99×10
−5; pgenome = 0.148) respectively
(Figure 1). These SNPs are hereafter referred to as Marker
1 and Marker 2 respectively. A second analysis using Fast
Mixed Model to correct for population stratification gen-
erated results that were consistent with those described
above, conveying support for the CMH meta-analysis
(data not shown).
Haplotype and homozygosity analysis
SNP homozygosity analysis of the region between Marker
1 or Marker 2 did not reveal a haplotype that was homo-
zygous in all cases and no controls (data not shown). In a
region 500 kb upstream of Marker 1 on CFA8 (62.647 to
63.084 Mb) a 437 kb region was identified for which all of
the PRA cases were homozygous (Homozygous Block,
Figure 2). However, five of the controls were also homozy-
gous for the “affected” haplotype in this region. There was
also a larger region comprising 21 SNPs over which the
haplotypes of most of the cases were different from those
of the controls (Affected haplotype, Figure 2). Inferred
phasing of these SNP markers, spanning 668 kb, revealed
the presence of six haplotypes, one of which was homozy-
gous in 8/10 cases but none of the controls (Haplotype
number 1 in Figure 3). As this putative PRA-associatedhaplotype does not include Marker 1 or Marker 2, broad
critical regions were defined to ensure sequence coverage
of Markers 1 and 2 and the PRA-associated haplotype.
The critical regions therefore extend from 62.046 to
64.373 Mb (Critical region 1) and 71.147 to 72.634 Mb
(Critical region 2), defining regions of 2.327 and 1.487 Mb
respectively, and 3.814 Mb in total. Critical region 1 con-
tains 17 genes, 14 of which have human orthologues. Two
genes in the region have previously been associated with
inherited retinopathies in humans; Spermatogenesis asso-
ciated protein 7 (SPATA7) has been associated with juven-
ile RP and LCA [21], and tetratricopeptide repeat domain
8 (TTC8) with RP as well as Bardet-Biedl Syndrome (BBS)
[22-24]. Critical region 2 contains 11 genes, all of which
have human orthologues, none of which have previously
been associated with retinal disease in any species.
Sequencing
To identify potential disease-causing mutations we under-
took targeted resequencing of both critical regions in 10
dogs (five affected, two obligate carrier and three control
dogs). Repetitive DNA elements, making up 41% of the re-
gions, were masked during the design of custom RNA
baits and as a result approximately 59% of the 3.814 Mb
critical region was enriched and sequenced. More than
287 million reads were generated across all 10 DNA sam-
ples (representing a 14.7 Gb dataset), of which 73% were
mapped to the targeted regions on CFA8. Approximately
74% of the regions covered by RNA baits were sequenced
with more than 30× read coverage, and the average read
depth across the targeted region for each sample ranged
from 230× to 329×. We identified more than 25,000 SNPs
and 2,400 indels when compared with the CanFam2 ref-
erence sequence. Of these 666 SNPs and 168 indels
Figure 2 Critical region definition using homozygosity analysis. SNP genotypes for 10 PRA cases and 16 PRA controls, over one of the two
regions identified during the GWA study. The most associated SNP in the region, BICF2P582923 (Marker 1) at 63.614 is indicated with an arrow.
All 10 cases, as well as 5 of the controls, share a 437 kb homozygous block, while 8 cases and none of the controls share a larger homozygous
region (Affected haplotype) upstream of Marker 1.
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were identified that were predicted to alter the protein
product. One was a non-synonomous substitution in exon
12 of the SPATA7 gene (CFA8: 62,735,867 bp; c.A1378G),
resulting in a missense mutation (p.Thr460Ala). The
other provocative variant was a single base (adenine)
deletion in exon 8 of TTC8 (CFA8: 63,129,154; c.669delA;
Figure 4).
Transcript evaluation
All of the coding sequence of the SPATA7 and TTC8
retinal transcripts from a healthy dog of unknown age or
breed were successfully sequenced, confirming that both
genes are transcribed in the canine retina. The presence
of the SPATA7 variant, c.A1378G, in the healthy retinal
mRNA transcript was surprising. While there is a chance
the tissue could have come from a dog that had not yet
developed PRA, we think it unlikely. The location of this
variant was only modestly conserved at the DNA leveland poorly conserved at the amino acid level in 35
eutherian mammals (data not shown). In addition the
c.A1378G variant was predicted to be benign by SIFT [25]
and PolyPhen [26]. Taken together these data suggested
that the variant was unlikely to be pathogenic and it was
therefore eliminated from further investigation.
Our sequencing data indicated that two isoforms of
TTC8 are transcribed in the canine retina and intron-exon
boundaries are identical to those of the human and mouse
(Figure 5), which is in conflict with the boundaries pre-
dicted by Ensembl genebuild for the canine gene. We were
unable to sequence the full 5′ and 3′ UTRs for any iso-
form. From the sequencing of the retinal mRNA tran-
scripts of both isoforms we discovered that canine TTC8
(Genbank accession no JQ941743) contains 505 amino
acids and TTC82A (Genbank accession no JQ941742) con-
tains 515 amino acids (Figure 6), with molecular weights
of 57.571 kDa and 58.247 kDa respectively, predicted
using the ExPASy Proteomics Server [27].
Figure 4 IGV display of the 1-bp deletion in TTC8 (c.669delA).
Each of the three samples (PRA-affected, obligate carrier and control)
viewed in IGV are represented by two panels. The upper panel is a
histogram where the height of each column is representative of the
read depth at that location. The lower panel is a graphical view of
some of the reads that align to that location. The “A” base indicated is
absent in almost all reads in the PRA-affected sample, approximately
half the reads in the obligate carrier and sample and none of the reads
in the PRA-unaffected (control) sample.
Figure 3 Fine mapping using haplotype analysis. SNP genotypes for 10 PRA cases and 16 PRA controls, over the 668 kb “Affected haplotype”
identified during the GWA study. Inferred phasing of the 21 SNP markers revealed six unique haplotypes. Haplotype number 1 (yellow) is homozygous
in 8/10 cases, but none of the controls.
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frame-shifting deletion of a single adenine in exon 8
(TTC8c.669delA in transcript ENSCAFT00000050179, CFA8:
63,129,154). The deletion was predicted to cause a prema-
ture stop codon (p.Lys223ArgfsX15), possibly resulting in
the degredation of mRNA by nonsense-mediated decay
or a truncated protein product (Figure 6). TTC8c.669delA
affects both isoforms of the protein.
Mutation screening
We screened all the 26 GR dogs (10 cases and 16 controls)
that were included in the GWA study for the coding vari-
ant, TTC8c.669delA, to confirm the association of this vari-
ant with PRA and compare it with the most highly
associated SNP markers, Marker 1 and Marker 2. The
variant showed significant allelic association with PRA
(praw = 6.31 × 10
−7, pgenome = 0.019) and was more strongly
associated than both Marker 1 at 63.614 Mb (praw =
5.79 × 10−6, pgenome = 0.109) and Marker 2 at 71.732 Mb
(praw = 1.30×10
−6, pPgenome = 0.037). Eight out of ten PRA
cases and none of the controls were homozygous for
TTC8669delA. Both of the two remaining cases were homo-
zygous for the wildtype (normal) haplotype. Neither were
either of these two cases homozygous for the minor allele
at Marker 2; one was heterozygous and the other homozy-
gous for the wildtype/major allele. While the variant
showed incomplete association with PRA, it has a strong
likelihood of a deleterious effect on the protein. In
addition, the nucleotide and the amino acid affected by
TTC8c.669delA is conserved in 32 eutherian mammals (data
not shown). This mutation is therefore highly likely to
be the causal mutation for GR_PRA2. Analysis of the
Figure 5 Graphical comparison of the exons and intron-exon boundaries of human and canine TTC8. (A) Mouse (Mus muscularis) TTC8.
(B) Human (Homo sapien) TTC8. (C) Canine (Canis familiaris) TTC8 as predicted by Ensembl genebuild. Thirteen of the genebuild exons predicted
are identical to the human exons (black). Exon 2 (grey) is different at the 3′ intron-exon boundary. Exons 3, 8, 9 and 10 (grey) show no sequence
or size similarity to their human equivalents and are probably incorrect. (D) Canine TTC8 exons confirmed by sequencing the retinal mRNA transcript.
Exon 2A has not been predicted by Ensembl genebuild. The location of the sequence variant is indicated.
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Swedish ancestry (Additional file 1: Figure S1) indicated
that PRA2 is recessive and fully penetrant.
We screened 2474 additional GR dogs, making a total
of 2500 GRs (29 PRA affected that were not caused by
GR_PRA1 or PRCD, five obligate carriers, 459 unaffected
dogs of any age and 2007 dogs of unknown clinical status)
tested for the TTC8c.669delA mutation (Table 1), to confirm
that it is not a commonly occurring polymorphism in this
breed. Of the 29 PRA cases included in the study 22
(75.9%) were homozygous for TTC8c.669delA (TTC8
−/−)
and all 464 dogs known to be clinically free of PRA atFigure 6 Effect of TTC8c.669delA on the protein. A) The normal retina-speci
The proteins differ only with the presence or absence of 10 amino acids uniq
identical in both isoforms. B) Both isoforms are affected by the c.669delA vari
223 of the ubiquitous isoform are normal. However the deletion causes a shif
termination codon. This results in a truncated protein product, lacking 267 res
therefore absent.their last eye examination, including five obligate carriers
of PRA, were either carriers of the mutant allele (3.9%;
TTC8+/−) or homozygous for the wildtype allele (96.1%;
TTC8+/+). The mutation described here accounts for PRA
cases from the UK, Sweden, France, Finland and USA. A
subset of the complete sample cohort were used to calcu-
late allele frequencies in populations within five countries
(Table 2).
To determine whether TTC8c.669delA is associated with
PRA in related breeds we screened a further 175 dogs
from three closely related breeds that could realistically
share polymorphisms with the GR; 48 Chesapeake Bayfic and ubiquitous isoforms encode 515 and 505 amino acids respectively.
ue to the retina-specific isoform (grey). The remainder of the protein is
ant. 233 amino acids at the N-terminus of the retina-specific protein and
t in the reading frame of 15 amino acids, leading to a premature
idues of the C-terminus of both isoforms. More than half of the protein is
Table 1 PRA2 genotypes and PRA clinical status for 2500 GRs
PRA clinical status
Genotypei PRA case PRA obligate carrier Clear Unknown Total
TTC8−/− 22 (75.9%) 0 (0%) 0 (0%) 4 (0.2%) 26
TTC8+/− 1 (3.4%) 2 (40.0%) 16 (3.5%) 130 (6.5%) 149
TTC8+/+ 6 (20.7%) 3 (60.0%) 443 (96.5%) 1873 (93.3%) 2325
Total 29 5 459 2007 2500
iThe wildtype allele is represented by “+” and the mutant allele by “-”.
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LRs, including 19 LRs and 2 CBRs that were clinically
affected with PRA but that were clear of the prcd muta-
tion. One LR with PRA was homozygous for the muta-
tion (TTC8−/−). The remaining 70 LR, 45 CBR and 59
FCR dogs were homozygous wildtype (TTC8+/+).
Additional phenotyping
One of the GRs with PRA in our cohort that was homozy-
gous for TTC8c.669delA was reported to have clinical signs
in addition to PRA. These were described as “hormonal
changes and thyroid problems” by the dog’s owner/
veterinarian, the precise nature of which are unknown,
and attempts to gather further information pertaining
to the phenotype of this dog were unsuccessful.
Assessment of systemic clinical signs in additional dogs
that were homozygous for TTC8c.669delA was attempted,
by means of an owner-completed questionnaire, but
unfortunately only 2/10 were completed and returned:
1. A bitch, diagnosed with PRA at the age of 5.9 years
was reported to be in good health. She was short for
the breed, at 30 kg was overweight for her size and
gained weight easily. She had undergone metabolism
tests (details of which were not reported), and while
not treated, the results were considered borderline
abnormal. The owner also reported that the dog had
never been able to catch a ball in the air, suggesting
it had poor coordination.
2. A dog, diagnosed with PRA at 2.9 years, was
reported to be in good health until his death at
9 years, from cancer. At 52 cm tall, he was
considered small for the breed, but was not
overweight. The owner reported two behavioural
idiosyncrasies: he was aggressive towards certainTable 2 Frequency of TTC8c.669delA in various countries
Country of ancestry
UK Sweden Denmark France USA
Number tested 88 736 132 87 179
TTC8c.669delA frequency 0.011 0.042 0.045 0.034 0.011
1 in # affected expected 7700 560 480 840 8000
1 in # carriers expected 45 12 12 15 45people when in the home, but not outside, and he
also appeared to have a poor sense of smell.
Discussion
In Golden Retrievers, mutations in two genes (SLC4A3
and PRCD) causing PRA in the breed have been de-
scribed [18,19]. These mutations account for approxi-
mately 61% of cases of PRA [18]. The PRCD mutation
appears to be very rare in the breed [28]. Indeed, we
have not identified any dogs homozygous for the PRCD
mutation, and less than 2% are carriers of the mutation.
Using a GWA analysis approach, we have identified a
third causal mutation for PRA in the GR, a novel muta-
tion in the TTC8 gene. We found that while this muta-
tion does not explain all remaining cases of PRA in our
study, suggesting that there is at least one more genetic-
ally distinct form of PRA in this breed, it does appear to
be fully penetrant and a common cause of PRA in the
breed.
Sequencing of SPATA7 and TTC8 from healthy retinal
mRNA served four purposes: 1. It confirmed the pres-
ence of both mRNA transcripts in the normal canine
retina. 2. The presence of the SPATA7c.A1378G variant in
mRNA from a healthy dog allowed the elimination of
this variant from further investigation. 3. It revealed that
the intron-exon boundaries predicted by the CanFam2
annotation for TTC8 in the dog are incorrect for five
exons. They are instead identical to the human and mouse
boundaries (Figure 5). 4. It revealed an exon orthologous
to human exon 2A, that is absent from the Ensembl ca-
nine (CanFam2) prediction (Figure 5). As is the case in
humans and mice, canine TTC8 is alternatively spliced
to produce two isoforms (TTC8 and TTC82A). The pre-
cise functional difference between the two isoforms is
unknown, but it is thought TTC82A plays in important
role in the function of the protein in the photoreceptor
cell-containing outer nuclear layer of the retina [23].
In order to further test the validity of the insertion mu-
tation, we screened 2500 GRs for the mutation (Table 1).
We found that 75.9% of the PRA cases (not caused by
PRCD or GR_PRA1), 40% of the obligate PRA carriers
and 100% of clinically unaffected dogs (which could be
clear of the mutation or carry a single copy) have TTC8
genotypes that are concordant with their clinical status.
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the mutation i.e. TTC8−/−, have developed PRA, suggest-
ing that the mutation is fully penetrant within the Golden
Retrievers investigated. The inheritance observed in a
family of eight dogs (three cases) is supportive of a re-
cessive mode (Additional file 1: Figure S1). The pres-
ence of the variant in GR dogs from countries including
the USA, UK, France, Denmark and Sweden suggests
the variant may have arisen prior to the geographic dis-
persion of the breed. The mutant allele frequencies indi-
cate that between 1 in 480 and 1 in 8000 GRs is likely to
be affected with this form of PRA, although up to 1 in
12 are expected to carry the mutant gene. There is a
group of dogs with genotypes discordant with their
phenotypes, comprising 7 PRA-affected dogs that are
not homozygous for TTC8c.669delA and three obligate
carriers that do not carry TTC8c.669delA. It is formally
possible that the mutation has a dominant mode of in-
heritance with incomplete penetrance, or complex trait
or compound heterozygote effects, although we have no
evidence to suggest this might be the case. Indeed, only
1/7 PRA-affected dogs that are not homozygous for
TTC8c.669delA is heterozygous and could therefore po-
tentially be a compound heterozygote. A further three
of these seven dogs are heterozygous at the GR_PRA1
(SLC4A3) locus, and PRA in these dogs could potentially
be caused by compound heterozygosity in SLC4A3. How-
ever, the three remaining dogs are homozygous for the
wildtype alleles at all three loci described to date i.e.
SLC4A3, TTC8 or PRCD, suggesting a fourth locus must
be causing PRA in these dogs. The observation that none
of these seven dogs are heterozygous at more than one
locus suggests that the additive effects of heterozygosity is
unlikely to be the cause of PRA in these dogs. Given that
three distinct loci have now been implicated in PRA in the
breed, these data taken together suggest it is likely that still
more loci are responsible for the discordant cases.
The absence of the mutant TTC8 allele from FCR and
CBR dogs tested, including some dogs affected with
PRA, indicates that the mutation is rare and probably
mainly confined to the GR breed, although identification
of a LR (with clinically apparent PRA) homozygous for
the variant suggests it may be present in the LR breed as
well. However, as only 1/19 LR PRA cases, all of which
have previously tested clear for prcd, is caused by the
TTC8 variant, it is clearly a minor cause of PRA in the
breed.
The PRA cases in our study that were homozygous for
the TTC8 variant had an average age of diagnosis of
4.51 years, while the discordant GR PRA cases i.e. TTC8+/+
and TTC8+/− had an average age at diagnosis of 6.46 years.
This difference could be indicative of the segregation of
a fourth form of PRA in the GR breed, with a slightly
older age of onset than GR_PRA2, although the age atdiagnosis may not necessarily accurately reflect the age
of onset.
TTC8 (a.k.a. BBS8) encodes the protein tetratricopeptide
repeat domain 8 and was recognised as a candidate gene
due to its previous implication in BBS and autosomal
recessive RP in humans [22-24]. TTC8 is one of seven
BBS proteins that form a stable complex known as the
BBSome, which functions primarily at the ciliary mem-
brane and is thought to play a role in ciliogenesis [20].
BBS is a pleiotropic disease and typical symptoms in-
clude obesity, retinal degeneration, kidney malforma-
tion, olfactory deficits, polydactyly, learning disabilities
and ataxia or poor coordination. While the syndrome is
usually inherited in an autosomal recessive manner,
triallelic inheritance has also been observed [29]. Human
TTC8 is made up of 14 exons and alternative splicing of
the fifth exon results in two isoforms that are widely
expressed [22]. In addition a retina-specific isoform, local-
ized to the outer nuclear layer, is created by the alternative
splicing of exon 2A [23]. While PRA is widely considered
to be the veterinary equivalent of RP, the limited charac-
terisation of PRA at a cellular level is insufficient to fully
justify this comparison. Further investigations are required
to understand the cellular processes involved in this form
of PRA, including whether the rod or cone photoreceptor
cells are affected first. While most mutations that signifi-
cantly alter the structure of TTC8 cause BBS in humans,
those that result in in-frame deletion or skipping of the 10
amino acids encoded by exon 2A cause non-syndromic
RP (Figure 7). The TTC8c.669delA variant in the GR is pre-
dicted to have a significant effect on the structure of the
protein, including the loss of all tetratricopeptide repeat
(TPR) motifs near the carboxyl terminus (Figure 6),
known to be protein-protein interaction motifs [22]. Most
of the affected dogs, however, presented with typical PRA
and no additional clinical signs that we were made aware
of. It is possible that other clinical signs in the dog have
simply not been reported to, or by, the examining ophthal-
mologists. One dog with PRA2 was reported to have “hor-
monal changes and thyroid problems”, the precise nature
of which are unknown. Attempts to gain further informa-
tion pertaining to this dog have thus far been unsuccessful.
Signs seen in two other dogs (small stature, obesity, aber-
rant metabolism and olfaction, and unusual behaviour), as
reported by their owners, suggest there may be more to
the phenotype of PRA2 than simply PRA. As the signs re-
ported are subjective, an objective, clinical investigation is
warranted. Attempts to conduct a clinical examination of
these dogs have been unsuccessful as the dogs were un-
available. Nevertheless, it is clear there are phenotypic
differences between human BBS and canine PRA2, as the
variety of symptoms that are seen in human patients are
not seen in the dog. It is unclear whether these phenotypic
differences are purely due to species-specific differences or
Figure 7 Comparison of human and canine retinal disease mutations. In humans, only mutations in exon 2A cause RP (orange [23]), while
mutations elsewhere have been associated with BBS (yellow [22] and blue [24]). TTC8c.669delA (purple) is associated with PRA in GRs.
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of modifier genes. The TTC8 protein is clearly critical to
ensure efficient function of ciliated tissue in humans, as
demonstrated by the BBS phenotype. In contrast, it may
be that the TTC8 protein is critical for photoreceptor
function in dogs, but less so in other tissues, perhaps due
to compensatory effects of other proteins. This would
explain a retina-specific or possibly less severe systemic
phenotype in dogs. Alternatively, in non-retinal tissues
there may be other proteins that compensate for the loss
of TTC8 in dogs more than in humans.
Conclusions
The identification of a frameshift deletion in TTC8 in
GR dogs with PRA, that is likely to be a significant suscep-
tibility locus for PRA in this breed, establishes PRA2 as a
model for human RP, and potentially BBS. This form of
PRA in the GR may prove to be a valuable model for
further studies to enhance our understanding of visual
pathways and gene therapy investigations.
Methods
Sample processing
The diagnosis of individual dogs was provided by veterin-
ary ophthalmologists through the BVA/KC/ISDS (British
Veterinary Association/Kennel Club/International Sheep
Dog Society) Eye Scheme in the UK, the Swedish Kennel
Club Eye Scheme in Sweden and independent veterinary
ophthalmologists. Cases were defined as dogs diagnosed
as affected with PRA i.e. displaying ophthalmoscopic signs
of PRA including tapetal hyperreflectivity and vascular
attenuation and controls as those free of inherited eye
disease of any kind, and at least 7 years old at the time
of examination for the GWA analysis or any age for
subsequent investigations.
Blood samples were collected into EDTA tubes and
genomic DNA was either extracted manually fromperipheral blood leukocytes using QIAamp DNA Blood
Midi Kit (Qiagen, Hilden, Germany) or automatically
on a QIAsymphony SP/AS instrument (Qiagen, Hilden,
Germany). DNA was also extracted from whole blood
using a Nucleon Genomic DNA Extraction Kit (Tepnel
Life Sciences, Manchester, UK), according to the manu-
facturer’s instructions. For samples collected as buccal
mouth swabs, DNA was extracted using a QIAamp®
DNA Blood Midi Kit (Qiagen, West Sussex, UK). A canine
retinal tissue sample from a dog of unknown breed and
free of PRA was taken post mortem, with the owner’s con-
sent. RNA was extracted using an RNeasy Protect Mini
Kit (Qiagen, West Sussex, UK) according to the manufac-
turer’s instructions.PRCD and PRA1 screening
We genotyped DNA from 29 PRA-affected GRs for the
PRCD and PRA1 mutations. The former was performed
using the TaqMan allelic discrimination technique (Ap-
plied Biosystems Inc., Foster City, CA) according to the
manufacturer’s instructions. Primers (Forward: 5′-GGC
CTTTCTCCTGCAGACT-3′; Reverse: 5′-CAGCTTCT
CACGGTTGGAC-3′) and PrimeTime Dual-Labelled
Probes (G-probe: 5′-FAM-AGCCATGTGCACCACCCT
CT-BHQ-3′ and C-probe: 5′-HEX-TGAGCCATGTAC
ACCACCCTCT-BHQ-3′; IDT, Glasgow, UK) were de-
signed with Primer3 [30]. PCR amplification and allelic
discrimination plate read and analysis were carried out on
a Techne Quantica Real Time Thermal Cycler with the
Quansoft software (Bibby Scientific Limited, Staffordshire,
UK). The PRA1 genotyping was performed by PCR
amplification using fluorescent primers (Forward: 5′-6-
FAM-AGAGCAACCTTGTAACCCGTA-3′ and Reverse:
5′-GGAAGAAGGCAATGAGAAAGG-3′; IDT, Glasgow,
UK) and subsequent fragment length polymorphism
detection using an ABI 3130xl DNA Analyzer and
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Genome-wide association mapping
CanineHD BeadChips (Illumina) were used to obtain
genotype calls for 173,662 SNPs using DNA from 10 GR
PRA cases and 16 GR controls and GWA analysis was
conducted using the software package PLINK [31]. After
removing SNPs with a minor allele frequency <5% and
missing genotype calls >10% from the analysis, a final
data set of 103,264 markers remained. Sample call rate
was >99.7% for all samples. Identity-by-state (IBS) cluster-
ing and Cochran–Mantel–Haenszel (CMH) meta-analysis
with PLINK were used to examine and adjust for popula-
tion stratification. As a correction for multiple testing, we
repeated the GWA analyses using the Max(T) permuta-
tion procedure in PLINK (100,000 permutations, denoted
by pgenome). An additional analysis using Fast Mixed
Model (FMM) to correct for population stratification was
also undertaken [32]. Haplotype phases were inferred
using PHASE [33]. Visual inspection of SNP genotypes
and haplotypes across the region was performed to define
a homozygous critical region.
Next generation sequencing
Genomic DNA (3 μg) from 10 GR dogs (five PRA-
affected, two obligate carrier and three PRA-clear) was
used to prepare DNA libraries for sequencing, using the
SureSelectXT Custom MP4 Kit (Agilent Technologies).
Each kit contained a custom capture library of 34,097 bi-
otinylated RNA baits, 120 bp in length and designed
based on the CanFam2 reference sequence using Agilent
Technologies’ eArray tool [34]. Baits were designed to
give 2× coverage and exclude repeat-masked regions,
resulting in coverage of 59.1% (2.25/3.81 Mb) of the tar-
geted regions. Target enrichment was performed accord-
ing to the manufacturer’s instructions. Initial shearing of
genomic DNA using a Covaris S220 and quality assess-
ment of the final library using a 2100 Bioanalyser was
undertaken by The Eastern Sequence and Informatics
Hub (EASIH, University of Cambridge). The quantity of
the captured library was assessed by quantitative PCR
using the KAPA Library Quantification Kit for the Illumina
Genome Analyzer Platform (KAPA Biosystems), according
to the manufacturer’s instructions.
Paired-end sequencing resulting in 51-bp reads was
conducted in a single lane on an Illumina Hiseq 2000,
by the High Throughput Group (HTG) at the Welcome
Trust Centre for Human Genetics (University of Oxford,
UK). Sequence reads were aligned with the canine refer-
ence sequence (CanFam 2) using BWA [35], variant (SNP
and indel) calls were made using GATK [36] and the
aligned reads were visualised using the Integrative Gen-
omics Viewer (IGV) [37]. Variants considered candidatesfor further investigation were those that occurred in splice
sites or resulted in non-synonymous changes to a protein,
and that were homozygous in PRA cases, heterozygous in
obligate carriers and heterozygous or homozygous for the
wildtype allele in controls.
Sanger sequencing
The exon-intron boundaries of canine TTC8 and SPATA7
were defined by producing ClustalW [38] alignments
using the Ensembl predicted canine transcripts (TTC8:
ENSCAFG00000017478; SPATA7: ENSCAFG00000017354)
and available known mouse (TTC8: ENSMUSG000000
21013; SPATA7: ENSMUSG00000021007) and human
(TTC8: ENSG00000165533; SPATA7: ENSG00000042317)
Ensembl transcripts. Primer3 [30] was used to design
primers in the exons for the amplification of cDNA as well
as to design primers in introns seven and eight for the
amplification and sequencing of TTC8 exon 8 in genomic
DNA (Additional file 2: Table S1). SPATA7 and TTC8
mRNA sequence was amplified by reverse-transcriptase
PCR using SuperScript®II Reverse Transcriptase (Invitro-
gen) according to the manufacturer’s instructions. To
further investigate the remaining variant (TTC8c.669delA) in
a larger dataset exon 8 of TTC8 was amplified by polymer-
ase chain reaction (PCR) using HotStarTaq Plus DNA Poly-
merase (Qiagen) in genomic DNA from the 26 GRs that
were included in the GWA study. PCR products were puri-
fied using Multiscreen HTS-PCR filter plates (Millipore).
Amplification products were sequenced on an ABI 3130xl
DNA Analyzer using BigDye Terminator v3.1 (Applied
Biosystems) and sequence traces were assembled, ana-
lyzed and compared using the Staden Package [39].
The variant was analysed for association with PRA and
compared with the most associated SNP markers,
BICF2P582923 and BICF2G630416812, using the soft-
ware package PLINK [31].
Mutation screening
The suggestive causative mutation for PRA2 in exon 8,
TTC8c.669delA, was screened in 2500 GRs by PCR ampli-
fication using fluorescent primers (Forward: 5′-6-FAM-
TGCCCTTTCCACAGAGCAC-3′ and Reverse: 5′- CC
ATGTCTAAGCCCTTCACAA-3′; IDT, Glasgow, UK)
and subsequent fragment length polymorphism detection
using an ABI 3130xl DNA Analyzer and GeneMapper®
Software (Applied Biosystems, Inc., [ABI], Foster City,
CA). The panel of 2500 GRs of any age (including the
26 DNA samples already sequenced), was made up of
29 PRA cases, 5 obligate carriers, 459 clear dogs and
2007 dogs with unknown PRA clinical status. Included
in this cohort of 2500 dogs were 88 dogs of breeding
age (between one and eight years of age), unrelated at
the parent level (from 88 different dams and 88 different
sires) and of UK ancestry. Also included were 87 dogs
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dogs of Danish ancestry and 179 dogs of US ancestry,
collected specifically for allele frequency estimations. In
addition, samples from 175 dogs representing three
breeds that are closely related to the GR breed were also
included in the mutation screening: LR (n = 71), CBR
(n = 45) and FCR (n = 59).
Additional PRA2 phenotyping
Two dogs with PRA that were homozygous for
TTC8c.669delA were selected for additional phenotyping.
The owners of these dogs were asked to complete a
questionnaire assessing the overall health of their dog
as well as the presence of systemic clinical signs known
to be associated with BBS. These included kidney, re-
productive, olfactory and behavioural/social abnormal-
ities, obesity and diabetes mellitus.
Additional files
Additional file 1: Figure S1. Segregation of TTC8c.669delA in a GR family.
The segregation of TTC8c.669delA and PRA in a GR family of Swedish origin
is consistent with an autosomal recessive mode of inheritance. “Age at
last test” refers to the age of the dog at its last ophthalmoscopic
examination.
Additional file 2: Table S1. Primers for Sanger sequencing. The
sequence of primer pairs used for sequencing of mRNA and DNA, along
with the expected amplicon sizes. All primers were used with an
annealing temperature of 57°C.
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